The Laboratory Information Management System (LIMS) along with the consumable sector will emerge to enable integration of various workflow processes including online sample request, tracking of samples, centralized web accessible data and customer billing.
The global automation market for bio banking applications was estimated to be $818 M in 2011, increasing at a CAGR of 8.2 %. By 2018 it will reach $1,415.5 M. Europe and North America were the major contributors with 41 % and 40 % of the revenue generated.
Automated liquid handling and robotics represents 59.3 % resulting Automated Compound Storage and Sample Management Systems with 16.3%, LIMS with 11.6% and consumables with 12.8%. Each year, almost 100 M samples are being supplemented to the global biobanks.
The industry’s major opportunities include increased LIMS capabilities and the flourishing growth in Europe and Asia, while the challenges are financial maintenance and funding of public biobanking infrastructure and automation in sectors such as retrieval systems and ultra-low cold sample storage.
Frost & Sullivan recently hosted an on-demand analyst summary titled ‘Automated Biobanking – The Next Big Leap for Biorepositories.’ The web-conference includes the findings of Ms Ravishankar. The findings result from observations such as identifying the drivers and restraints related to automating biobanks, the growth of automation within the biobanking sector, and defining the organizational challenges hindering the growth of automation.
Professionals of various sectors benefited by this web-conference include distributors, component manufacturers, and biobanking integration software vendors who deliver LIMS solutions for biobanks and tools to automate liquid/sample handling or compound storage.